King Pharmaceuticals KG GLS — Paid losses

Similar metrics at other companies

CINFPersonal Insurance — Paid loss and loss expenses

$515.25M+31.7%

CINFCommercial Insurance — Paid loss and loss expenses

$575.5M-1.4%

PRA

PRASpecialty P&C — Paid losses and loss adjustment expenses, net of reinsurance

$167.02M-2.4%

CINFReinsurance assumed and other non segment — Paid loss and loss expenses

$98.25M+56.0%

ORIGeneral Liability — Cumulative Paid Loss and Allocated Loss Adjustment Expenses, Net of Reinsurance

$736.7M+512%

AIZGlobal Lifestyle — Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance

$7.57B+372%

Questions, answered.

What is King Pharmaceuticals's GLS — paid losses?

King Pharmaceuticals (KG) reported GLS — paid losses of $1.85M in Q4 2025.

What does GLS — paid losses mean?

This represents the actual cash outflows made by the segment to settle insurance claims during a specific period. Unlike loss reserves, which are estimates, paid losses reflect realized cash impacts on liquidity. Tracking this metric helps investors understand the current claims settlement velocity and cash flow requirements of the insurance business.